Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003)

International Journal of Urology

Volumn 13, Issue 5, 2006, Pages 538-542

  Shigemura, Katsumi ^a   Arakawa, Soichi ^a   Sakai, Yutaka ^c   Kinoshita, Shohiro ^b   Tanaka, Kazushi ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Pseudomonas aeruginosa; Urinary tract catheter; Urinary tract infection

Indexed keywords

AMIKACIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CISPLATIN; DOXORUBICIN; GENTAMICIN; METHOTREXATE; MINOCYCLINE; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VINBLASTINE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLADDER TUMOR; CLINICAL FEATURE; COLONY FORMING UNIT; FEMALE; FEVER; HUMAN; INCIDENCE; INDWELLING CATHETER; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URINARY TRACT CARCINOMA; URINARY TRACT INFECTION; URINE CATHETER;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 33646811202     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01359.x     Document Type: Article

References (22)

1. Gastmeier P, Kampf G, Wischnewski N et al. Prevalence of nosocomial infections in representative German hospitals. J. Hosp. Infect. 1998 38:37 49.
2. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the Global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 2001 32 Suppl. 2 S146 55.
3. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 2001 32 Suppl. 2 S133 45.
4. Spencer RC. An 8-year Microbe Base survey of the epidemiology, frequency, and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. J. Antimicrob. Chemother. 1996 37:295 301.
5. Gruneberg RN. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992. J. Antimicrob. Chemother. 1994 33 Suppl. A 1 8.
6. MacGowan AP, Brown NM, Holt HA, Lovering AM, McCulloch SY, Reeves DS. An eight-year survey of the antimicrobial susceptibility patterns of 85 9 71 bacteria isolated from patients in a district general hospital and the local community. J. Antimicrob. Chemother. 1993 31:543 57.
7. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB. Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J. Antimicrob. Chemother. 1999 44:359 65.
8. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB. Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J. Antimicrob. Chemother. 1999 44:359 65.
9. Dyer IE, Sankary TM, Dawson JA. Antibiotic resistance in bacterial urinary tract infections, 1991-1997. West. J. Med. 1998 169:265 8.
10. Thomson KS, Sanders WE, Sanders CC. USA resistance patterns among UTI pathogens. J. Antimicrob. Chemother. 1994 33 Suppl. A 9 15.
11. Weber G, Riesenberg K, Schlaeffer F, Peled N, Borer A, Yagupsky P. Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991-1995. Eur. J. Clin. Microbiol. Infect. Dis. 1997 16:834 8.
12. Spencer RC. An 8-year Microbe Base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. J. Antimicrob. Chemother. 1996 37:295 301.
13. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically. NCCLS Document M7-A5. NCCLS, Wayne, 2000.
14. Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am. J. Med. 1998 85:793 8.
15. Sobell JD, Kayle D. Urinary tract infections. In:Mandell GL, Bennett JE, Dolin E (eds). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Churchill Livingstone, Philadelphia, 2000 773 805.
16. Kahlmeter G. The ECO*SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J. Antimicrob. Chemother. 2000 46 Suppl. A 15 22.
17. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin. Infect. Dis. 2001 33:89 94.
18. Mathai D, Jones RN, Pfaller MA. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn. Microbiol. Infect. Dis. 2001 40:129 36.
19. Ono Y. Pseudomonas aeruginosa. Nippon Rinsho 2002 60:2150 5.
20. Cordero L, Sananes M, Coley B et al. Ventilator-associated pneumonia in very low-birth-weight infants at the time of nosocomial bloodstream infection and during airway colonization with Pseudomonas aeruginosa. Am. J. Infect. Control 2000 28:333 9.
21. Uema K, Kagawa T, Takigawa H, Kurokawa K. Clinical bacterial investigation in inpatients of department of urology. Nishinihon Hinyoukika 1987 49:1089 98.
22. Kumon H, Ono N, Iida M, Nickel JC. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm. Antimicrob. Agents Chemother. 1995 39:1038 44.